(Q39313548)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801507%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

HO-3867, a STAT3 inhibitor induces apoptosis by inactivation of STAT3 activity in BRCA1-mutated ovarian cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801507%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801507%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Brent J Tierney

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801507%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Georgia A McCann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801507%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Eric Eisenhauer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801507%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Meryl Sudhakar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801507%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Periannan Kuppusamy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801507%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Kálmán Hideg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801507%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Karuppaiyah Selvendiran

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801507%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

1 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801507%20AND%20SRC:MED&resulttype=core&format=json

Cancer Biology and Therapy

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801507%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801507%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801507%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

766-775

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801507%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

cites work

BRCA1 and transcription

1 reference

SGO White Paper on ovarian cancer: etiology, screening and surveillance

21 January 2018

1 reference

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

21 January 2018

1 reference

Characterization of BRCA1 and BRCA2 mutations in a large United States sample

21 January 2018

1 reference

Identification of BRCA1-deficient ovarian cancers.

21 January 2018

1 reference

PARP inhibitors in BRCA gene-mutated ovarian cancer and beyond

21 January 2018

1 reference

Molecular functions of BRCA1 in the DNA damage response

21 January 2018

1 reference

Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo

21 January 2018

1 reference

Cellular uptake, retention and bioabsorption of HO-3867, a fluorinated curcumin analog with potential antitumor properties

21 January 2018

1 reference

Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenyl piperidones: differential cytotoxicity in healthy and cancer cells

21 January 2018

1 reference

EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression

21 January 2018

1 reference

HO-3867, a synthetic compound, inhibits the migration and invasion of ovarian carcinoma cells through downregulation of fatty acid synthase and focal adhesion kinase

21 January 2018

1 reference

Anticancer efficacy of a difluorodiarylidenyl piperidone (HO-3867) in human ovarian cancer cells and tumor xenografts

21 January 2018

1 reference

Oxidative stress, redox, and the tumor microenvironment

21 January 2018

1 reference

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

21 January 2018

1 reference

Prospective strategies to enforce selectively cell death in cancer cells

21 January 2018

1 reference

The STATs of cancer--new molecular targets come of age

21 January 2018

1 reference

Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells.

21 January 2018

1 reference

Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer

21 January 2018

1 reference

Concomitant activation of the JAK/STAT3 and ERK1/2 signaling is involved in leptin-mediated proliferation of renal cell carcinoma Caki-2 cells

21 January 2018

1 reference

Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells

21 January 2018

1 reference

Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids

21 January 2018

1 reference

HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition

21 January 2018

1 reference

Bcl-2 family proteins as targets for anticancer drug design

21 January 2018

1 reference

Bcl-2-family proteins and the role of mitochondria in apoptosis

21 January 2018

1 reference